← Leaderboards
Herbert Cubasch
Wits Health Consortium (Pty), Ltd
$331,878
Attributed
$1,991,270
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $474.8K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,991,270 · 1
By mechanism
R01$1,991,270 · 1
Top collaborators
- Wafaa M. El-Sadr6 shared
- Judith S Jacobson6 shared
- Maureen Joffe6 shared
- Alfred I Neugut6 shared
- Paul Ruff6 shared
Most similar at Wits Health Consortium (Pty), Ltd
Same institution · by research overlap
- Glenda E Gray$398,868,516
- Michele Michele Ramsay$12,183,837
- Ian Matthias Sanne$46,166,067
- Helen Rees$13,006,752
- Paul Ruff$759,247
Others in their field
Other Emerging Leaders on “Sociodemographics”
- Anusha Murthy Vable · University Of California, San Francisco$6,992,435
- Stephen F Smagula · University Of Pittsburgh At Pittsburgh$5,369,879
- Kimberly Ann Miller · University Of Southern California$5,296,556
- Van My Ta Park · University Of Pennsylvania$4,979,434
- Jet M.j. Vonk · Columbia University Health Sciences$4,890,622
- Stephanie L. Schmit · H. Lee Moffitt Cancer Ctr & Res Inst$4,433,917
Research focus
SociodemographicsMortalityHospitalsResearch PersonnelSurvival PredictionSouth AfricaFundingHiv SeronegativityMalignant NeoplasmsPatient-Focused OutcomesSouth AfricanStudentsUniversitiesWomanComorbidityFemaleGrantBreast Cancer PatientLinkMalignant Breast NeoplasmMentorsCharacteristicsAcademic Medical CentersChemotherapy
Grant awards (6)
Novel predictors of survival among breast cancer patients with/without HIV in South Africa$345,761
R01 · FY2024 · CA
Novel predictors of survival among breast cancer patients with/without HIV in South Africa$347,160
R01 · FY2023 · CA
Novel predictors of survival among breast cancer patients with/without HIV in South Africa$124,999
R01 · FY2023 · CA
Novel predictors of survival among breast cancer patients with/without HIV in South Africa$348,517
R01 · FY2022 · CA
Novel predictors of survival among breast cancer patients with/without HIV in South Africa$474,837
R01 · FY2021 · CA
Novel predictors of survival among breast cancer patients with/without HIV in South Africa$349,996
R01 · FY2020 · CA